Keeping in mind the steady and continuous advancing cancer treatment and novel biomarkers in LC; The four proteins, mutl homolog 2, mutl homolog 1, mutl homolog 6, and postmitotic segregating increased 2, should be evaluated by immunohistochemistry (IHC). This evidence concerns the gene MLH1 and cancer.